Position in TOVX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$20,675
+$14,321 QoQ
Shares Held
82,700
+7709.3% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 24 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TOVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. TOVX ranks #408 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in TOVX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,675 | 82,700 | Shares | Defined | 2026-08-13 | |
| 2024-06-30 | $6,354 | 26,477 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,501 | 26,599 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $11,437 | 26,599 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $14,363 | 26,599 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $26,599 | 26,599 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $24,989 | 35,699 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $16,064 | 35,699 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $35,342 | 35,699 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||